{"id":41713,"date":"2025-09-17T15:50:12","date_gmt":"2025-09-17T07:50:12","guid":{"rendered":"https:\/\/flcube.com\/?p=41713"},"modified":"2025-09-17T15:50:13","modified_gmt":"2025-09-17T07:50:13","slug":"eli-lilly-unveils-5-b-virginia-facility-to-scale-bioconjugate-antibody-production","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41713","title":{"rendered":"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production"},"content":{"rendered":"\n<p><strong>Eli Lilly (<a href=\"https:\/\/www.google.com\/finance\/quote\/LLY:NYSE\">NYSE: LLY<\/a>)<\/strong> announced plans to construct a <strong>$5\u202fbillion<\/strong> manufacturing complex just west of Richmond in Goochland County. The new site will be the company\u2019s first fully integrated active pharmaceutical ingredient (API) and drug\u2011product plant dedicated to its emerging bioconjugate platform and monoclonal\u2011antibody portfolio, which spans oncology, autoimmune disease, and other advanced therapies.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-part-of-a-50-b-u-s-expansion-play\">Part of a $50\u202fB U.S. Expansion Play<\/h4>\n\n\n\n<p>Earlier this year, Lilly disclosed a commitment to build four new domestic pharmaceutical facilities as part of a <strong>$50\u202fbillion<\/strong> U.S. capital\u2011expenditure program launched in 2020. The Virginia plant is the first of the four announced sites, with plans to unveil the remaining three later in 2025. All four facilities are slated to begin production within five years, reinforcing Lilly\u2019s strategy to strengthen domestic supply chains for high\u2011complexity biologics.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-workforce-amp-economic-impact\">Workforce &amp; Economic Impact<\/h4>\n\n\n\n<p>The Virginia project is expected to create <strong>more than 650 high\u2011paying jobs<\/strong>\u2014engineers, scientists, operations staff, and lab technicians\u2014alongside <strong>\u22481,800 construction positions<\/strong> during the build\u2011out. Local officials anticipate substantial economic benefits, from increased tax revenue to expanded demand for housing and services.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-cutting-edge-technology\">Cutting\u2011Edge Technology<\/h4>\n\n\n\n<p>Lilly will embed advanced digital tools across the new plant, leveraging <strong>machine learning, artificial intelligence, and automated manufacturing systems<\/strong> to enhance yield, reduce variability, and accelerate time\u2011to\u2011market for antibody\u2011drug conjugates (ADCs) and other bioconjugates.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-looking-ahead\">Looking Ahead<\/h4>\n\n\n\n<p>\u201cThe Virginia facility will not only bolster Lilly\u2019s bioconjugate and antibody\u2011drug conjugate capabilities but also position the company to meet evolving patient needs with faster, more reliable supply chains,\u201d said <strong>Eli\u202fLilly CEO<\/strong>. The company remains focused on deploying next\u2011generation manufacturing technologies across its U.S. portfolio to sustain its competitive edge in the biologics market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly (NYSE: LLY) announced plans to construct a $5\u202fbillion manufacturing complex just west of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41714,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[199,911],"class_list":["post-41713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-eli-lilly","tag-nyse-lly"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Eli Lilly (NYSE: LLY) announced plans to construct a $5\u202fbillion manufacturing complex just west of Richmond in Goochland County. The new site will be the company\u2019s first fully integrated active pharmaceutical ingredient (API) and drug\u2011product plant dedicated to its emerging bioconjugate platform and monoclonal\u2011antibody portfolio, which spans oncology, autoimmune disease, and other advanced therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41713\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41713\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-17T07:50:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-17T07:50:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1711.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production\",\"datePublished\":\"2025-09-17T07:50:12+00:00\",\"dateModified\":\"2025-09-17T07:50:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713\"},\"wordCount\":299,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1711.webp\",\"keywords\":[\"Eli Lilly\",\"NYSE: LLY\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41713#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41713\",\"name\":\"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1711.webp\",\"datePublished\":\"2025-09-17T07:50:12+00:00\",\"dateModified\":\"2025-09-17T07:50:13+00:00\",\"description\":\"Eli Lilly (NYSE: LLY) announced plans to construct a $5\u202fbillion manufacturing complex just west of Richmond in Goochland County. The new site will be the company\u2019s first fully integrated active pharmaceutical ingredient (API) and drug\u2011product plant dedicated to its emerging bioconjugate platform and monoclonal\u2011antibody portfolio, which spans oncology, autoimmune disease, and other advanced therapies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41713\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1711.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1711.webp\",\"width\":1080,\"height\":608,\"caption\":\"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate & Antibody Production\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41713#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production - Insight, China&#039;s Pharmaceutical Industry","description":"Eli Lilly (NYSE: LLY) announced plans to construct a $5\u202fbillion manufacturing complex just west of Richmond in Goochland County. The new site will be the company\u2019s first fully integrated active pharmaceutical ingredient (API) and drug\u2011product plant dedicated to its emerging bioconjugate platform and monoclonal\u2011antibody portfolio, which spans oncology, autoimmune disease, and other advanced therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41713","og_locale":"en_US","og_type":"article","og_title":"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=41713","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-17T07:50:12+00:00","article_modified_time":"2025-09-17T07:50:13+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1711.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41713#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41713"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production","datePublished":"2025-09-17T07:50:12+00:00","dateModified":"2025-09-17T07:50:13+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41713"},"wordCount":299,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41713#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1711.webp","keywords":["Eli Lilly","NYSE: LLY"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41713#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41713","url":"https:\/\/flcube.com\/?p=41713","name":"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41713#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41713#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1711.webp","datePublished":"2025-09-17T07:50:12+00:00","dateModified":"2025-09-17T07:50:13+00:00","description":"Eli Lilly (NYSE: LLY) announced plans to construct a $5\u202fbillion manufacturing complex just west of Richmond in Goochland County. The new site will be the company\u2019s first fully integrated active pharmaceutical ingredient (API) and drug\u2011product plant dedicated to its emerging bioconjugate platform and monoclonal\u2011antibody portfolio, which spans oncology, autoimmune disease, and other advanced therapies.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41713#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41713"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41713#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1711.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1711.webp","width":1080,"height":608,"caption":"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate & Antibody Production"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41713#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eli\u202fLilly Unveils $5\u202fB Virginia Facility to Scale Bioconjugate &amp; Antibody Production"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1711.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41713"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41713\/revisions"}],"predecessor-version":[{"id":41715,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41713\/revisions\/41715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41714"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}